Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Efficacy and Tolerance Data Collection in 34 to 36 Weeks Preterm Neonates Treated by High Flow Nasal Cannula for Respiratory Distress Syndrom

NCT02958488 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT02958488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02958488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Efficacy and Tolerance Data Collection in 34 to 36 Weeks Preterm Neonates Treated by High Flow Nasal Cannula for Respiratory Distress Syndrom
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
March 16, 2016
Completion date
August 25, 2020
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high flow nasal cannula, respiratory distress syndrom